ACTIVE

AGRICELLS

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-1,1 M €
-764.4% YoY
Gross margin
-977,6 k €
-541.7% YoY
Equity
2,2 M €
+37.6% YoY

What does AGRICELLS do?

AGRICELLS is a Public limited company incorporated in 2020. Its registered office is in Marche-en-Famenne.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0742.991.393
Incorporation
06/02/2020
Legal form
Public limited company
Registered office
Aye, Rue de la Science 8
6900 Marche-en-Famenne · WallonieSee on map
Contributed capital
3 677 742,16 €
Latest accounts
31/12/2025
Signals
Solid equityLow riskGood liquidity
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 6 financial years

202520242023202220212020
Income statement
Gross margin-977,6 k €221,3 k €-1,2 M €-604,4 k €-814,2 €-99,5 k €
EBITDA-977,6 k €201,3 k €-1,2 M €-732,6 k €-814,2 €-99,5 k €
Operating result-1,2 M €160,5 k €-1,6 M €-914,8 k €-165,1 k €-177,1 k €
Net result-1,1 M €160,2 k €-948,3 k €-916,0 k €-165,5 k €-177,2 k €
Balance sheet
Equity2,2 M €1,6 M €1,5 M €126,2 k €1,0 M €757,8 k €
Total assets3,5 M €1,8 M €1,6 M €278,7 k €1,0 M €776,9 k €
Cash683,6 k €253,1 k €644,2 k €255,6 k €983,6 k €761,0 k €
Debts1,3 M €229,4 k €133,1 k €152,4 k €–19,1 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
At this address

Other companies at this address

CompanyCBE no.
Association pour le développement des Productions Agroalimentaires de qualité● Active
0416.914.413
Association pour l'Usage et la Défense de l'Appellation Jambon d'Ardenne● Active
0457.901.762
ASSOCIATION POUR L'USAGE ET LA DEFENSE DU SAUCISSON D'ARDENNE● Active
0863.356.814
ATB THERAPEUTICS● Active
0677.980.015
Bureau d’Administration ATB THERAPEUTICS● Active
1031.100.991
CER-Groupe● Active
0420.654.158
INVESTY CORPORATE● Active
1008.960.841
Orgenesis (Belgium)● Bankrupt
0540.866.555
ORGENESIS SERVICES SRL● Bankrupt
0790.353.624
RevaTis● Active
0541.682.642
REVATIS VET● Active
1015.868.627
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)● Active
0731.712.273
Annual accounts

Full financial information

202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date18/08/202605/08/202517/07/202423/06/202315/08/202212/08/2021
General meeting03/06/202623/06/202530/05/202413/04/202321/06/202216/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

6 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202503/06/202618/08/2026FrenchPDF
Micro model31/12/202423/06/202505/08/2025FrenchPDF
Micro model31/12/202330/05/202417/07/2024FrenchPDF
Micro model31/12/202213/04/202323/06/2023FrenchPDF
Micro model31/12/202121/06/202215/08/2022FrenchPDF
Micro model31/12/202016/06/202112/08/2021FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates17/04/2025
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Capital / shares17/07/2024
    CAPITAL, ACTIONS
    PDF
  • Mandates02/06/2023
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates01/03/2021
    SIEGE SOCIAL - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - MODIFICATION FORME JURIDIQUE
    PDF
  • Other10/02/2020
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-1,1 M €↓
  2. 2024
    Annual accounts 2024160,2 k €↑
  3. 2023
    Annual accounts 2023-948,3 k €↓
  4. 2022
    Annual accounts 2022-916,0 k €↓
  5. 2021
    Annual accounts 2021-165,5 k €↑
  6. 2020
    Annual accounts 2020-177,2 k €
  7. 06/02/2020
    IncorporationPublic limited company